Secreted semaphorin 5a activates immune effector cells and is a biomarker for rheumatoid arthritis

Arthritis and Rheumatology

Volumn 66, Issue 6, 2014, Pages 1461-1471

  Gras, Christiane ^a   Eiz Vesper, Britta ^a   Jaimes, Yarua ^a,b   Immenschuh, Stephan ^a   Jacobs, Roland ^a   Witte, Torsten ^a   Blasczyk, Rainer ^a   Figueiredo, Constança ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; ORPHAN NUCLEAR RECEPTOR; PLEXIN; PLEXIN A1; PLEXIN B3; RHEUMATOID FACTOR; SEMAPHORIN; SEMAPHORIN 5A; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL SURFACE; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; HUMANS; KILLER CELLS, NATURAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; RHEUMATOID FACTOR; SJOGREN'S SYNDROME; T-LYMPHOCYTES;

EID: 84901599532     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38425     Document Type: Article

References (49)

1. Kolodkin AL, Matthes DJ, Goodman CS,. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 1993; 75: 1389-99.
2. Gherardi E, Love CA, Esnouf RM, Jones EY,. The sema domain. Curr Opin Struct Biol 2004; 14: 669-78.
3. Eickholt BJ,. Functional diversity and mechanisms of action of the semaphorins. Development 2008; 135: 2689-94.
4. Adams RH, Betz H, Puschel AW,. A novel class of murine semaphorins with homology to thrombospondin is differentially expressed during early embryogenesis. Mech Dev 1996; 57: 33-45.
5. Bahri SM, Chia W, Yang X,. Characterization and mutant analysis of the Drosophila sema 5c gene. Dev Dyn 2001; 221: 322-30.
6. Sadanandam A, Rosenbaugh EG, Singh S, Varney M, Singh RK,. Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis. Microvasc Res 2009; 79: 1-9.
7. Sadanandam A, Varney ML, Singh S, Ashour AE, Moniaux N, Deb S, et al. High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis [published erratum appears in Int J Cancer 2012;130:E2]. Int J Cancer 2010; 127: 1373-83.
8. Sadanandam A, Varney ML, Kinarsky L, Ali H, Mosley RL, Singh RK,. Identification of functional cell adhesion molecules with a potential role in metastasis by a combination of in vivo phage display and in silico analysis. OMICS 2007; 11: 41-57.
9. Pan GQ, Ren HZ, Zhang SF, Wang XM, Wen JF,. Expression of semaphorin 5A and its receptor plexin B3 contributes to invasion and metastasis of gastric carcinoma. World J Gastroenterol 2009; 15: 2800-4.
10. Matsuoka RL, Chivatakarn O, Badea TC, Samuels IS, Cahill H, Katayama K, et al. Class 5 transmembrane semaphorins control selective mammalian retinal lamination and function. Neuron 2011; 71: 460-73.
11. Artigiani S, Conrotto P, Fazzari P, Gilestro GF, Barberis D, Giordano S, et al. Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep 2004; 5: 710-4.
12. Takamatsu H, Okuno T, Kumanogoh A,. Regulation of immune cell responses by semaphorins and their receptors. Cell Mol Immunol 2010; 7: 83-8.
13. Wang X, Kumanogoh A, Watanabe C, Shi W, Yoshida K, Kikutani H,. Functional soluble CD100/Sema4D released from activated lymphocytes: possible role in normal and pathologic immune responses. Blood 2001; 97: 3498-504.
14. Kim CW, Cho EH, Lee YJ, Kim YH, Hah YS, Kim DR,. Disease-specific proteins from rheumatoid arthritis patients. J Korean Med Sci 2006; 21: 478-84.
15. Okuno T, Nakatsuji Y, Kumanogoh A,. The role of immune semaphorins in multiple sclerosis. FEBS Lett 2011; 585: 3829-35.
16. Sugimoto M, Fujikawa A, Womack JE, Sugimoto Y,. Evidence that bovine forebrain embryonic zinc finger-like gene influences immune response associated with mastitis resistance. Proc Natl Acad Sci U S A 2006; 103: 6454-9.
17. McInnes IB, Schett G,. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007; 7: 429-42.
18. Firestein GS,. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356-61.
19. Hot A, Miossec P,. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann Rheum Dis 2011; 70: 727-32.
20. Miltenburg AM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC,. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 1992; 35: 603-10.
21. Buch MH, Boyle DL, Rosengren S, Saleem B, Reece RJ, Rhodes LA, et al. Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study. Ann Rheum Dis 2009; 68: 1220-7.
22. 3 to control human Th17-mediated synovial inflammation. Ann Rheum Dis 2012; 71: 606-12.
23. bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol 2004; 173: 6418-26.
24. Conigliaro P, Scrivo R, Valesini G, Perricone R,. Emerging role for NK cells in the pathogenesis of inflammatory arthropathies. Autoimmun Rev 2011; 10: 577-81.
25. Sadanandam A, Sidhu SS, Wullschleger S, Singh S, Varney ML, Yang CS, et al. Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation. Br J Cancer 2012; 107: 501-7.
26. Taylor P, Gartemann J, Hsieh J, Creeden J,. A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis [published erratum appears in Autoimmune Dis 2012;2012:734069]. Autoimmune Dis 2011; 2011: 815038.
27. Gras C, Eiz-Vesper B, Seltsam A, Immenschuh S, Blasczyk R, Figueiredo C,. Semaphorin 7A protein variants differentially regulate T-cell activity. Transfusion 2013; 53: 270-83.
28. Figueiredo C, Goudeva L, Horn PA, Eiz-Vesper B, Blasczyk R, Seltsam A,. Generation of HLA-deficient platelets from hematopoietic progenitor cells. Transfusion 2010; 50: 1690-701.
29. Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL,. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
30. + progenitor cells. J Thromb Haemost 2012; 10: 1100-8.
31. Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM, McKinstry KK, et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol 2009; 182: 3469-81.
32. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher LH,. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000; 100: 655-69.
33. Browne K, Wang W, Liu RQ, Piva M, O'Connor TP,. Transmembrane semaphorin5B is proteolytically processed into a repulsive neural guidance cue. J Neurochem 2012; 123: 135-46.
34. Schulze-Koops H, Kalden JR,. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2001; 15: 677-91.
35. Lubberts E, Koenders MI, van den Berg WB,. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 2005; 7: 29-37.
36. Hendrich C, Kuipers JG, Kolanus W, Hammer M, Schmidt RE,. Activation of CD16+ effector cells by rheumatoid factor complex: role of natural killer cells in rheumatoid arthritis. Arthritis Rheum 1991; 34: 423-31.
37. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B,. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis 2004; 63: 1090-5.
38. Syversen SW, Gaarder PI, Goll GL, Odegard S, Haavardsholm EA, Mowinckel P, et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2008; 67: 212-7.
39. Feldmann M, Brennan FM, Maini RN,. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440.
40. + T helper cells. Cell 2006; 126: 1121-33.
41. Firestein GS, Zvaifler NJ,. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that γ-interferon is not the primary macrophage activating factor. Arthritis Rheum 1987; 30: 864-71.
42. Canete JD, Martinez SE, Farres J, Sanmarti R, Blay M, Gomez A, et al. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon γ is highly expressed in synovium of rheumatoid arthritis compared to seronegative spondyloarthropathies. Ann Rheum Dis 2000; 59: 263-8.
43. Cannella AC, O'Dell JR,. Early rheumatoid arthritis: pitfalls in diagnosis and review of recent clinical trials. Drugs 2006; 66: 1319-37.
44. Sauerland U, Becker H, Seidel M, Schotte H, Willeke P, Schorat A, et al. Clinical utility of the anti-CCP assay: experiences with 700 patients. Ann N Y Acad Sci 2005; 1050: 314-8.
45. Ohta S, Harigai M, Tanaka M, Kawaguchi Y, Sugiura T, Takagi K, et al. Tumor necrosis factor-α (TNF-α) converting enzyme contributes to production of TNF-α in synovial tissues from patients with rheumatoid arthritis. J Rheumatol 2001; 28: 1756-63.
46. Charbonneau M, Harper K, Grondin F, Pelmus M, McDonald PP, Dubois CM,. Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor α-induced increases in tumor necrosis factor-α converting enzyme/ADAM17 expression by synovial cells. J Biol Chem 2007; 282: 33714-24.
47. Van Oosterhout M, Bajema IM, Levarht EW, Toes RE, Huizinga TW, van Laar JM,. Synovial differences between anti-CCP positive and anti-CCP negative rheumatoid arthritis [abstract]. Arthritis Rheum 2007; 56 Suppl: S198.
48. Koch AE,. Angiogenesis: implications for rheumatoid arthritis [review]. Arthritis Rheum 1998; 41: 951-62.
49. Vadasz Z, Attias D, Kessel A, Toubi E,. Neuropilins and semaphorins: from angiogenesis to autoimmunity. Autoimmun Rev 2010; 9: 825-9.